With steatosis | Without steatosis | P-value | |
---|---|---|---|
Mean duration (months) | 23 ± 12.8 | 38.82 ± 20.11 | 0.024 |
Mean cDD (g) | 37.77 ± 19. 43 | 67.98 ± 36.39 | 0.015 |
Type of ARB | 0.722 | ||
Losartan | 8 (30. 8%) | 19 (69.2%) | |
Valsartan | 3 (37.5%) | 5 (62.5%) | |
Duration of use | 0.037 | ||
< 20 months | 5 (62.5%) | 3 (23.1%) | |
≥ 20 months | 6 (37.5%) | 20 (76.9%) | |
Mean cDDD | 0.048 | ||
< 20 (g) | 4 (66.7%) | 21 (75%) | |
≥ 20 (g) | 7 (25%) | 2 (33.3%) |